2014 annual financial data
Travere Therapeutics 2014 Operating margin
Direct answer
Operating margin was -282.97%.
Operating income was -79,807,693 USD and net income was -110,937,862 USD.
Operating cash flow was -45,849,750 USD.
Get free Travere Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 28,203,205 USD
- Operating income
- -79,807,693 USD
- Net income
- -110,937,862 USD
- Operating cash flow
- -45,849,750 USD